A phase 1, single blind, placebo-controlled, randomized study to assess the safety of DS-1040b in subjects with thombectomy-treated acute ischemic stroke.

Trial Profile

A phase 1, single blind, placebo-controlled, randomized study to assess the safety of DS-1040b in subjects with thombectomy-treated acute ischemic stroke.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs DS 1040 (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 01 Aug 2017 Status changed from not yet recruiting to recruiting.
    • 14 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top